260 related articles for article (PubMed ID: 19604468)
1. Ocular complications of childhood rheumatic diseases: nonuveitic inflammatory eye diseases.
Reiff A
Curr Rheumatol Rep; 2009 Jul; 11(3):226-32. PubMed ID: 19604468
[TBL] [Abstract][Full Text] [Related]
2. Ocular complications of childhood rheumatic diseases: uveitis.
Reiff A
Curr Rheumatol Rep; 2006 Dec; 8(6):459-68. PubMed ID: 17152145
[TBL] [Abstract][Full Text] [Related]
3. Ophthalmologic manifestations of rheumatic diseases.
Hamideh F; Prete PE
Semin Arthritis Rheum; 2001 Feb; 30(4):217-41. PubMed ID: 11182023
[TBL] [Abstract][Full Text] [Related]
4. [Rheumatic diseases and ocular features].
Usui M; Kumakura S; Suzumura H; Kimura N; Iino T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():229-36. PubMed ID: 15799351
[No Abstract] [Full Text] [Related]
5. Rheumatic inflammatory eye diseases of childhood.
Reiff A; Kadayifcilar S; Özen S
Rheum Dis Clin North Am; 2013 Nov; 39(4):801-32. PubMed ID: 24182856
[TBL] [Abstract][Full Text] [Related]
6. The eye in rheumatology.
Morarji J; Lightman S; Taylor SR
Br J Hosp Med (Lond); 2011 Dec; 72(12):682-5. PubMed ID: 22241225
[TBL] [Abstract][Full Text] [Related]
7. Current perspectives on ophthalmic manifestations of childhood rheumatic diseases.
Palejwala NV; Yeh S; Angeles-Han ST
Curr Rheumatol Rep; 2013 Jul; 15(7):341. PubMed ID: 23686303
[TBL] [Abstract][Full Text] [Related]
8. Ocular manifestations of rheumatologic disorders.
Poole TR; Graham EM
Curr Opin Ophthalmol; 1999 Dec; 10(6):458-63. PubMed ID: 10662252
[TBL] [Abstract][Full Text] [Related]
9. [Ocular symptoms in rheumatic diseases].
Bobrzyk M; Łabuzek K; Orski M; Tarnawska D; Okopień B
Pol Merkur Lekarski; 2014 May; 36(215):357-60. PubMed ID: 24964517
[TBL] [Abstract][Full Text] [Related]
10. [Eye in rheumatic diseases].
Vukojević N
Reumatizam; 2011; 58(2):13-23. PubMed ID: 22232942
[TBL] [Abstract][Full Text] [Related]
11. Neuro-ophthalmologic manifestations of rheumatologic and associated disorders.
Borruat FX
Curr Opin Ophthalmol; 1996 Dec; 7(6):10-8. PubMed ID: 10166547
[TBL] [Abstract][Full Text] [Related]
12. Ocular manifestations in Iranian patients referred to rheumatology clinics from 2018 to 2020.
Pournazari M; Hashemi T; Zarpoosh M; Amirian P
Immun Inflamm Dis; 2023 May; 11(5):e863. PubMed ID: 37249299
[TBL] [Abstract][Full Text] [Related]
13. Rheumatologic disease and associated ocular manifestations.
Mahoney BP
J Am Optom Assoc; 1993 Jun; 64(6):403-15. PubMed ID: 8335882
[TBL] [Abstract][Full Text] [Related]
14. Ocular Involvement in Selected Rheumatic Diseases - Clinical Manifestation in Adulthood.
Baquet-Walscheid K; Rath T; Heiligenhaus A
Klin Monbl Augenheilkd; 2024 May; 241(5):626-632. PubMed ID: 38574680
[TBL] [Abstract][Full Text] [Related]
15. [Problems associated with treating ocular disease in underlying inflammatory rheumatic disease].
Zierhut M; Kötter I; Lorenz HM
Z Rheumatol; 2010 Jul; 69(5):393-6. PubMed ID: 20577747
[TBL] [Abstract][Full Text] [Related]
16. Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.
Peponis V; Kyttaris VC; Chalkiadakis SE; Bonovas S; Sitaras NM
Lupus; 2010 May; 19(6):675-82. PubMed ID: 20144965
[TBL] [Abstract][Full Text] [Related]
17. Complications of Treatments for Pediatric Rheumatic Diseases.
Higgins GC
Pediatr Clin North Am; 2018 Aug; 65(4):827-854. PubMed ID: 30031500
[TBL] [Abstract][Full Text] [Related]
18. The eye in systemic inflammatory diseases.
McCluskey P; Powell RJ
Lancet; 2004 Dec 11-17; 364(9451):2125-33. PubMed ID: 15589311
[TBL] [Abstract][Full Text] [Related]
19. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: I. Damage to important organs whose early treatment makes a big difference; 10. Eye].
Kawashima H
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2607-12. PubMed ID: 24400541
[No Abstract] [Full Text] [Related]
20. Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement.
Olivieri I; Accorinti M; Abicca I; Bisceglia P; Cimino L; Latanza L; Leccese P; Lubrano E; Marchesoni A; Miserocchi E; Neri P; Salvarani C; Scarpa R; D'Angelo S;
Rheumatol Int; 2018 Sep; 38(9):1727-1734. PubMed ID: 29961101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
